Hippocampal type I and type II corticosteroid receptors are differentially regulated by chronic prazosin treatment

Neuroscience

Volumn 73, Issue 4, 1996, Pages 963-970

  Kabbaj, M ^a   Le Moal, M ^a   Maccari, S ^a  

^a INSERM   (France)

Author keywords

corticosterone; hippocampus; type I and type II corticosteroid receptors; 1 noradrenergic transmission

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; NORADRENALIN; PRAZOSIN; RECEPTOR SUBTYPE;

ADRENALECTOMY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CUSHING SYNDROME; DEPRESSION; DRUG TARGETING; FEEDBACK SYSTEM; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENERGIC SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029943881     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00086-3     Document Type: Article

References (61)

1. Adell A. and Artigas F. (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytyptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch. Pharmac. 343, 237-244.
2. Al-Damluji S., Perry L., Tomlin S., Bouloux P., Grossman A., Rees L. H. and Besser G. M. (1987) Alpha adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 45, 68-76.
3. Angelucci L., Patacchiolli F. R., Bohus B. and De Kloet E. R. (1981) Serotonin innervation and glucocorticoid binding in the hippocampus: relevance to depression. In Typical and Atypical Antidepressants. Molecular Mechanisms (eds Costa E. and Racagni), pp. 365-370. Raven, New York.
4. Angelucci L., Patacchiolli F. R., Taglialatela G., Maccari S., Ramacci M. T. and Ghirardi O. (1986) Brain glucocorticoid receptors and adrenocortical activity are sensitive markers of senescence retarding treatment in rats. In Modulation of Central and Peripheral Transmitter Function (eds Biggio G., Spano P. F., Toffano G. and Gessa G. L.), pp. 347-352. Liviana Press, Padova.
5. Anisman H. and La Pierre Y. (1982) Neurochemical aspects of stress and depression: Formulation and caveats. In Psychological Stress and Psychopathology (ed. Neufeld R. W.), pp. 199-217. McGraw-Hill, New York.
6. Anton R. F. (1987) Urinary free cortisol in psychotic depression. Biol. Psychiat. 22, 24-34.
7. Baker G. B. and Greenshaw A. J. (1989) Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell molec. Neurobiol. 9, 1-44.
8. Callera J. C., Camargo L. A., De Luca Junior L. A., Menani J. V., Renzi A. and Saad W. A. (1993) Clonidine and phenylephrine injected into lateral preoptic area reduce water intake in dehydrated rats. Pharmac. Biochem. Behav. 46, 39-43.
9. Canny B. J. (1990) Hippocampal glucocorticoid receptors and the regulation of ACTH secretion. Molec. cell. Endocrinol. 71, C35-C38.
10. Casolini P., Piazza P. V., Kabbaj M., Le Prat F., Angelucci L., Simon H., Le Moal M. and Maccari S. (1993) The mesolimbic dopaminergic system exerts an inhibitory influence on brain corticosteroid receptor affinities. Neuroscience 55, 429-434.
11. 2 agonist LY 171555 decreases the affinity of type II corticosteroid receptors in rat hippocampus and ventral striatum. Neuroscience 60, 939-943.
12. Cavero I. and Roach A. G. (1980) The pharmacology of prazosin, in novel antihypertensive agent. Life Sci. 27, 1525-1540.
13. Chan J. Y., Pan S. and Chan S. H. (1991) Participation of noradrenergic neurotransmission in angiotensin III-induced dipsogenic behavior in the rat. Life Sci. 48, 1293-1301.
14. Chou Y. C. and Luttge W. G. (1988) Activated type II receptors in brain cannot bind glucocorticoids: relationship to progesterone's antiglucocorticoid actions. Brain Res. 440, 67-78.
15. Crews F. T., Paul S. M. and Goodwin F. K. (1981) Acceleration of β-receptor desensitization in combined administration of antidepressants and phenoxybenzamine. Nature 290, 787-789.
16. Cummings S. and Seybold V. (1988) Relationship of alpha-1 and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. Neuroendocrinology 47, 523-532.
17. Dallman M. F., Levin N., Cascio C. S., Akana S. F., Jacobson L. and Kuhn R. W. (1989) Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology 124, 2844-2850.
18. De Kloet E. R. and Reul J. M. H. M. (1987) Feed back action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 124, 83-105.
19. De Leon M. J., McRae T., Tsai J. R., George A. E., Marus D. L., Freedman L., Wolf A. P. and McEwen B. S. (1988) Abnormal cortisol in alzheimer's disease linked to hippocampal atrophy. Lancet ii: 391.
20. Dienstbier R. A. (1989) Arousal and physiological thoughness: implications for mental and physical health. Psychol. Rev. 96, 84-100.
21. Evans D. L. and Nemeroff C. B. (1987) The clinical use of dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. J. Psychiat. Res. 21, 185-194.
22. Gadek-Michalska A., Turon M., Bugajski J. and Polczynska-Konior G. (1990) Effects of systemic and intracerebroventricular phenylephrine and clonidine on corticosterone secretion in rats. Endocrinol. Exp. 24, 249-258.
23. Joels M. and de Kloet E. R (1989) Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245, 1502-1505.
24. 1 noradrenergic receptors. Neuroscience 66, 539-549.
25. Kalimi M. E. and Hubbard J. R. (1983) Development of an exchange assay for cytosolic glucocorticoid receptors using the synergistic effects of molybdate plus dithiothreitol. Endocrinology 113, 1161-1163.
26. Keller-Wood M. E. and Dallman M. F. (1984) Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5, 1-24.
27. 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinology 56, 153-160.
28. Lowry O. H., Rosenbrough N., Farr A. L. and Randall R. J. (1951) Protein measurements with the folin phenol reagent. J. biol. Chem. 193, 265-267.
29. Lowy M. T. (1990) MK-801 antagonizes metamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors. Brain Res. 533, 348-352.
30. Maccari S., Le Moal M., Angelucci L. and Mormede P. (1990) Influence of 6-OHDA lesions of central noradrenergic systems on corticosteroid receptors and neuroendocrine responses to stress. Brain Res. 533, 60-65.
31. Maccari S., Mormede P., Piazza P. V., Simon H., Angelucci L. and Le MoaL M. (1992) Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems. Psychoneuroendocrinology 17, 103-112.
32. Maccari S., Piazza P. V., Deminiere J. M., Angelucci L., Simon H. and Le Moal M. (1991) Hippocampal type I and type II corticosteroid receptor affinities are reduced in rats predisposed to develop amphetamine self-administration. Brain Res. 548, 305-309.
33. Maccari S., Piazza P. V., Kabbaj M., Barbazanges A., Simon H. and Le Moal M. (1995) Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J. Neurosci. 15, 110-116.
34. Maccari S., Piazza P. V., Rouge-Pont F., Angelucci L., Simon H. and Le Moal M. (1992) Noradrenergic regulation of type-I and type-II corticosteroid receptors in amygdala and hypothalamus. Brain Res. 587, 313-318.
35. Marti O., Gavaldà A., Gomez F. and Amario A. (1994) Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to novel acute stressors. Neuroendocrinology 60, 1-7.
36. Matos F. F., Rollema H. and Basbaum A. I. (1990) Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis. Brain Res. 528, 39-47.
37. McEwen B. S (1987) Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem. Pharmac. 36, 1755-1759.
38. Meaney M., Viau V., Aitken D. H. and Bhatnagar S. (1988) Stress induced occupancy and translocation of hippocampal glucocorticoid receptors. Brain Res. 445, 198-203.
39. Melia K. R., Rasmussen K., Terwilliger R. Z., Haycock J. W., Nestler E. J. and Duman R. S. (1992) Co-ordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeroleus: effects of chronic stress and drug treatments. J. Neurochem. 58, 494-502.
40. Patacchioli F. R., Amenta F., Ramcci M. T., Tagliatella R., Maccari S., Angelucci L. (1989) Acetyl-carnitine reduced the age-dependent loss of glucocorticoid receptors in the rat hippocampus: an autoradiographic study. J. Neurosci. Res 23, 462-466.
41. Patacchioli P. R., Catalani A., Collia P., Scaccianoce S., Tagliatela G. and Angelucci L. (1986) Monoaminergic modulation of the hypothalamo-pituitary-adrenal axis during stress response in the rat. In Central Actions of ACTH and Related Peptides, Fidia Research Series, Symposia in Neuroscience IV (eds De Wied D. and Ferrari W.), pp. 131-138. Liviana, Padova.
42. Pepper G. M. and Krieger D. T. (1984) Hypothalamic-pituitary-adrenal abnormalities in depression: their possible relation to central mechanisms regulating ACTH release. In Neurobiology of Mood Disorders (eds Post R. M. and Ballenger J. C.), pp. 245-254. Williams and Wilkins, Baltimore.
43. Persky H. (1975) Adrenocortical function and anxiety. Psychoneuroendocrinology 1, 37-44.
44. Piazza P. V., Maccari S., Deminiere J. M., Le Moal M. and Simon H. (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. natn. Acad. Sci. U.S.A. 88, 2088-2092.
45. Ratka A., Sutanto W., Bloemers M. and de Kloet R. (1989) On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50, 117-123.
46. Reul J. M. H. M. and de Kloet E. R (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117, 2505-2511.
47. Reul J. M. H. M. and de Kloet E. R. (1987) Relative occupation of type-I and type II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J. Endocrinol. 115, 459-467.
48. Reul J. M. H. M., Stec I., Soder M. and Holsboer F. (1993) Chronic treatment of rats with the antidepressant Amitriptyline attenuates the activity of the Hypothalamic-Pituitary-Adrenal system. Endocrinology 133, 312-320.
49. Sapolsky R. M., Krey L. C. and McEwen B. S. (1983) The adrenocortical response in the aged rat: impairment of recovery from stress. J. exp. Gerontol. 18, 55-63.
50. Sapolsky R. M., Krey L. C. and McEwen B. S. (1983) Corticosterone receptors decline in a site specific manner in the aged rat. Brain Res. 289, 235-240.
51. Sapolsky R. M., Krey L. C. and McEwen B. S. (1984) Stress down-regulates corticosterone receptors in a site specific manner in the brain. Endocrinology 114, 287-292.
52. Sapolsky R. M., Krey L. C. and McEwen B. S. (1985) The adrenocortical axis in the aged rat: impaired sensitivity to both fast and delayed feed-back inhibition. Neurobiol. Agng 7, 331-335.
53. Sapolsky R. M., Krey L. C. and McEwen B. S. (1985) Prolonged glucocorticoid exposure reduces hippocampal neuron number: implication for aging. J. Neurosci. 5, 1222-1227.
54. Sapolsky R. M., Uno H., Rebert C. S. and Finch C. E. (1990) Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10, 2897-2902.
55. Scatchard G. (1949) The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660.
56. Seckl J. R., Dickson K. L. and Fink G. (1990) Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J. Neuroendocrinol. 2, 911-916.
57. Takao T., Hashimoto K. and Ota Z. (1988) Central catecholaminergic control of ACTH secretion. Regul. Pept. 21, 301-308.
58. Van Dijken H. H., De Goeij D. C. E., Sutanto W., De Kloet E. R. and Tilders F. J. H. (1993) Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats. Neuroendocrinology 58, 57-64.
59. Weidenfeld J. and Feldman S. (1991) Effect of 6-hydroxydopamine and 5,7-dihydroxytryptamine on tissue uptake and cell nuclear retention of corticosterone in the rat hypothalamus. Brain Res. 566, 140-145.
60. Yau J. L. W., Dow R. C., Fink G. and Seckl J. R. (1992) Medial septal cholinergic lesions increase hippocampal mineralocorticoid and glucocorticoid receptor messenger RNA expression. Brain Res. 577, 155-160.
61. Yau J. L. W. and Seckl J. R. (1992) Central 6-hydroxydopamine lesions decrease mineralocorticoid, but not glucocorticoid receptor gene expression in the rat hippocampus. Neurosci. Lett. 142, 159-162.